Immune response is less robust in people with low CD4 counts (<200/mm3) with evidence suggesting that a third primary dose of the COVID‐19 vaccine is effective in boosting a protective immune response against severe COVID‐19 disease in this group [19, 20]. The gene discussed is CD4; the disease is COVID-19.